Free tool
FAERS Monitor: Imodium A-D
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019487 or its brand name (Imodium A-D, Loperamide Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
44,941
Serious
27,585
61% of reports
Hospitalization
16,194
Death reported
3,911
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea8,976
- nausea4,323
- drug ineffective4,099
- fatigue3,916
- off label use3,251
- vomiting2,788
- constipation2,503
- weight decreased2,103
- headache2,046
- dyspnoea2,020
- decreased appetite1,843
- asthenia1,839
- abdominal pain1,818
- dizziness1,733
- pain1,651
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 355 |
| 2005 | 383 |
| 2006 | 393 |
| 2007 | 439 |
| 2008 | 529 |
| 2009 | 595 |
| 2010 | 639 |
| 2011 | 654 |
| 2012 | 1,057 |
| 2013 | 948 |
| 2014 | 1,140 |
| 2015 | 3,461 |
| 2016 | 2,284 |
| 2017 | 3,131 |
| 2018 | 3,200 |
| 2019 | 3,186 |
| 2020 | 3,123 |
| 2021 | 2,864 |
| 2022 | 3,372 |
| 2023 | 3,683 |
| 2024 | 3,569 |
| 2025 | 3,540 |
| 2026 | 2,393 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,009,218 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| diarrhoeaSignal | 8,976 | 6.6 | 6.5 | 43,254 |
| constipationSignal | 2,503 | 5.4 | 5.2 | 9,013 |
| decreased appetiteSignal | 1,843 | 3.7 | 3.6 | 3,700 |
| abdominal painSignal | 1,818 | 3.7 | 3.5 | 3,554 |
| weight decreasedSignal | 2,103 | 3.5 | 3.4 | 3,862 |
| vomitingSignal | 2,788 | 2.8 | 2.7 | 3,243 |
| nauseaSignal | 4,323 | 2.6 | 2.5 | 4,264 |
| fatigueSignal | 3,916 | 2.4 | 2.3 | 3,173 |
| astheniaSignal | 1,839 | 2.3 | 2.2 | 1,361 |
| off label use | 3,251 | 1.7 | 1.7 | 1,064 |
| dyspnoea | 2,020 | 1.7 | 1.6 | 559 |
| dizziness | 1,733 | 1.6 | 1.6 | 428 |
| headache | 2,046 | 1.5 | 1.5 | 384 |
| drug ineffective | 4,099 | 1.5 | 1.4 | 624 |
| pain | 1,651 | 1.3 | 1.2 | 90 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.